.png)
welcome
Login To Your Account
Our mission is to bring transparency and trust to global markets using cutting-edge AI technology to detect accounting manipulation and fraud in corporate financial statements.
our Awards and accreditations
Our awards and accreditations






Featured Insights
Think Transparently
Explore our resources to master the power of AI in financial analysis.
The Short Sellers Digest: Aya Gold & Silver, Praxis Precision, Trustpilot
Track short-seller targets and executive exits with Transparently’s forensic signals and accounting quality risk ratings. Updated weekly for investors.

Mark Jolley
December 8, 2025
How we do AI: The basics
Learn the basics of Transparently.ai's cutting-edge AI. Our system uses pattern recognition and vast data to detect potential accounting fraud with unmatched speed and consistency.

Mark Jolley
December 4, 2025
NIO: What our accounting risk system found before GIC’s lawsuit
Transparently’s AI-powered system flagged key accounting risks at NIO years before GIC’s fraud lawsuit, highlighting the predictive power of accounting risk models.

Mark Jolley
October 21, 2025
Can Transparently's risk engine generate alpha?
Discover how the Transparently Risk Engine uses AI to detect accounting manipulation and generate alpha. Learn how avoiding high-risk companies leads to increased returns.

Mark Jolley
July 9, 2025

Our AI-powered accounting risk trading strategy beat the S&P 500 by 2.5x
Learn about the AI-powered trading model based on accounting risk beats S&P 500 Index by 2.5x. Strategy shorts high-risk firms, goes long the US stock index.

Hamish Macalister
May 8, 2025
The Satyam scandal: Inside India’s Enron
Learn how the Satyam fraud scandal happened. Discover what Transparently's AI tool indicated about Satyam's accounting quality before the fraud took place.

Mark Jolley
March 12, 2025
India’s worst accounting scandals
Learn about India’s worst accounting scandals. Find out about accounting fraud at Yes Bank, Satyam Computer, Kingfisher and others in this report.

Mark Jolley
February 27, 2025
The Valeant scandal: Inside the Enron of pharma
Uncover the rise and fall of Valeant through its history of regulatory issues. Learn about the risky signals discovered in its financial statements.

Mark Jolley
November 22, 2024